TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government & Organizations

    Psychopharmacology and Psychiatry Updates

    Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

    Advertise
    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Staying Well: LAIs vs. Oral Medications in Cannabis-Induced Psychosis Mar 07, 2026
    Show notes

    In this episode, we explore groundbreaking research on treating cannabis-induced psychosis with antipsychotic medications. Which formulations cut hospitalization rates by 75%? And why do some commonly prescribed antipsychotics show no effectiveness at all in preventing future psychotic episodes?

    Faculty: David A. Gorelick, M.D., Ph.D., D.L.F.A.P.A., F.A.S.A.M. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.5 CMEs: Quick Take Vol. 78
    • Cannabis-Induced Psychosis: Which Antipsychotics Best Prevent Hospitalization?

    Adult ADHD: Optimizing Stimulant Therapy Mar 02, 2026
    Show notes

    In this episode, we explore stimulant medications for adult ADHD with Dr. Oscar Bukstein. Why have amphetamines overtaken methylphenidate as the most prescribed option? Discover how to match formulation duration to patient needs, navigate cardiovascular risks, and monitor treatment effectively for optimal outcomes in adult ADHD management.

    Faculty: Oscar G. Bukstein, M.D., M.P.H. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: Mastering Adult ADHD: A Comprehensive Clinical Guide
    • Pharmacologic Treatments for Adult ADHD: Focus on Stimulants

    Semaglutide for Clozapine-Induced Weight Gain: The COaST Trial Feb 25, 2026
    Show notes

    In this episode, we explore the groundbreaking COaST trial examining semaglutide for clozapine-induced weight gain in schizophrenia patients. Could GLP-1 agonists finally offer a real solution to one of psychiatry's most frustrating paradoxes—when the medication that saves lives simultaneously shortens them?

    Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.5 CMEs: Quick Take Vol. 78
    • Does Semaglutide Reverse Clozapine-Induced Weight Gain in Schizophrenia? Results from the COaST Trial

    Beyond Stimulants: Tailoring ADHD Treatment to Comorbidities Feb 20, 2026
    Show notes

    In this episode, we explore the treatment algorithm for adult ADHD with Dr. Oscar Bukstein from Harvard Medical School. Should you start with stimulants or non-stimulants when substance use disorder complicates the picture? Discover how comorbidities like depression and anxiety reshape your medication selection strategy for optimal patient outcomes.

    Faculty: Oscar G. Bukstein, M.D., M.P.H Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: Mastering Adult ADHD: A Comprehensive Clinical Guide
    • Treatment Algorithm for Adult ADHD

    Beyond Standard Treatment: Exploring Pramipexole in Bipolar Depression Feb 15, 2026
    Show notes

    In this episode, we explore pramipexole—a Parkinson's medication—as a promising add-on treatment for treatment-resistant bipolar depression. Could a dopamine agonist be the unexpected solution when standard mood stabilizers and antipsychotics fail? We examine the PAX-BD trial's findings, safety concerns, and practical clinical applications.

    Faculty: Kristin Raj, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.5 CME: Quick Take Vol. 78
    • Treatment-Resistant Bipolar Depression: Is Adjunctive Pramipexole An Option?

    SERT Gene Testing: Separating Hype from Evidence Feb 10, 2026
    Show notes

    In this episode, we explore the controversial role of SERT gene testing in predicting SSRI response with Dr. Chris Aiken. Can genetic testing really tell us which patients will respond to antidepressants, or are we putting too much faith in pharmacogenetic promises that lack solid evidence?

    Faculty: Chris Aiken, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: The Role of Genetic Testing in Psychiatry
    • SERT Gene and SSRI Response: Is It Clinically Useful?

    The SSRI-Anticoagulant Interaction: Evidence-Based Prescribing Strategies Feb 05, 2026
    Show notes

    In this episode, we explore a critical drug interaction: SSRIs combined with anticoagulants increase major bleeding risk by 35-47%. Should age and sex change our prescribing decisions? We break down the evidence from nearly 100,000 patients and discuss safer antidepressant alternatives for high-risk individuals.

    Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.75 CME: Quick Take Vol. 77
    • Do SSRIs Increase Major Bleeding Risk with Oral Anticoagulants?

    Pharmacogenetic Testing in Psychiatry: Help or Hype? Jan 31, 2026
    Show notes

    In this episode, we explore the paradox of pharmacogenetic testing with Dr. Chris Aiken: why do these tests consistently fail in clinical trials despite showing promise in understanding drug metabolism? Could industry bias and statistical noise be masking the truth about personalized psychiatric medicine?

    Faculty: Chris Aiken, M.D. Host: Richard Seeber, M.D.

    • Learn more about our memberships here
    • Earn 0.75 CME: The Role of Genetic Testing in Psychiatry
    • Pharmacogenetic Panels: Do They Really Work?

    Lurasidone: Managing Bipolar Depression with Comorbid Anxiety Jan 26, 2026
    Show notes

    In this episode, we explore how Lurasidone at lower doses (20-60 mg/day) effectively treats both depression and anxiety in bipolar I disorder. Why does the lower dose range outperform higher doses for patients with severe anxiety? Discover the surprising dose-dependent effects and metabolic advantages that make this a game-changer.

    Faculty: Kristin Raj, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here.
    • Earn 0.75 CMEs: Quick Take Vol. 77
    • Is Lurasidone Effective for Bipolar Depression with Comorbid Anxiety?

    GLP-1 Agonists vs. Antipsychotic Weight Gain Jan 21, 2026
    Show notes

    In this episode, we explore how GLP-1 agonists—the weight loss medications making headlines everywhere—could revolutionize management of antipsychotic-induced weight gain. Can these drugs help patients lose weight while maintaining psychiatric stability? We examine the latest evidence and discuss practical implementation strategies for your practice.

    Faculty: Oliver Freudenreich, M.D. Host: Richard Seeber, M.D.

    • Learn more about our membership here
    • Earn 0.75 CMEs: Quick Take Vol. 76
    • Antipsychotic-Induced Weight Gain: Are GLP-1 Agonists Effective?

    Previous 1 4 5 6 7 8 12 Next

    Related Podcasts

    The Joe Rogan Experience

    1

    The Joe Rogan Experience Comedy
    More Perfect

    2

    More Perfect Government
    Casefile True Crime

    3

    Casefile True Crime Games & Hobbies
    Reply All

    4

    Reply All Games & Hobbies
    You Must Remember This

    5

    You Must Remember This Games & Hobbies
    Real Time with Bill Maher

    6

    Real Time with Bill Maher Games & Hobbies
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights